C. Thompson

发表

The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding

D. Lowy, J. Schiller, P. Day, 2009, Proceedings of the National Academy of Sciences.

Arrangement of L2 within the Papillomavirus Capsid

B. Trus, D. Lowy, A. Steven, 2008, Journal of Virology.

Production of Papillomavirus‐Based Gene Transfer Vectors

C. Buck, C. Thompson, 2007, Current protocols in cell biology.

Virus-Like Particle–Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor Antigens

J. Schiller, Rhonda C. Kines, C. Thompson, 2021, Cancer Immunology Research.

Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1

D. Lowy, J. Schiller, P. Day, 2014, PLoS pathogens.

Characterization of Mus musculus Papillomavirus 1 Infection In Situ Reveals an Unusual Pattern of Late Gene Expression and Capsid Protein Localization

D. Lowy, J. Schiller, C. Buck, 2013, Journal of Virology.

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

D. Lowy, P. Castle, J. Schiller, 2004, Virology.

Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors

D. Lowy, J. Schiller, S. Sethi, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Human papillomavirus capsids preferentially bind and infect tumor cells

D. Lowy, J. Schiller, Rhonda C. Kines, 2016, International journal of cancer.

In vivo mechanisms of vaccine-induced protection against HPV infection.

D. Lowy, R. Roden, J. Schiller, 2010, Cell host & microbe.

Identification of a Role for the trans-Golgi Network in Human Papillomavirus 16 Pseudovirus Infection

D. Lowy, J. Schiller, Rachel M. Schowalter, 2013, Journal of Virology.

A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8+ Memory T Cells

D. Lowy, B. Graham, J. Schiller, 2019, The Journal of Immunology.

Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.

D. Lowy, R. Roden, J. Schiller, 2012, Virology.

The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane.

D. Lowy, J. Schiller, P. Day, 2015, Virology.

Topical Herpes Simplex Virus 2 (HSV-2) Vaccination with Human Papillomavirus Vectors Expressing gB/gD Ectodomains Induces Genital-Tissue-Resident Memory CD8+ T Cells and Reduces Genital Disease and Viral Shedding after HSV-2 Challenge

D. Lowy, J. Schiller, J. Cohen, 2014, Journal of Virology.

Maturation of Papillomavirus Capsids

D. Lowy, J. Schiller, C. Buck, 2005, Journal of Virology.

Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection

D. Lowy, J. Schiller, P. Day, 2019, Journal of Virology.

Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions

D. Lowy, J. Schiller, P. Day, 2022, Journal of virology.

Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

D. Lowy, R. Roden, J. Schiller, 2005, Virology.

A Human Papillomavirus (HPV) In Vitro Neutralization Assay That Recapitulates the In Vitro Process of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies

D. Lowy, J. Schiller, P. Day, 2012, Clinical and Vaccine Immunology.

Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan

P. Choyke, D. Lowy, M. Bernardo, 2007, Nature Medicine.

Carrageenan Is a Potent Inhibitor of Papillomavirus Infection

D. Lowy, J. Schiller, C. Buck, 2006, PLoS pathogens.

Neutralization of Human Papillomavirus with Monoclonal Antibodies Reveals Different Mechanisms of Inhibition

D. Lowy, J. Schiller, C. Buck, 2007, Journal of Virology.

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids

D. Lowy, J. Schiller, P. Day, 2015, Papillomavirus research.

Human α-defensins block papillomavirus infection

D. Lowy, J. Lubkowski, J. Schiller, 2006, Proceedings of the National Academy of Sciences of the United States of America.

A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging

Christopher B. Buck, Patricia M. Day, D. Lowy, 2015, Journal of Virology.

Maturation of the Human Papillomavirus 16 Capsid

B. Trus, D. Lowy, A. Steven, 2014, mBio.

Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism

D. Lowy, J. Schiller, P. Day, 2017, Journal of Virology.

Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas.

M. Frazier-Jessen, R. T. Brown, R. Nordan, 2000, Blood.

Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins

D. Lowy, J. Schiller, C. Thompson, 2018, International journal of cancer.

Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells.

P. Lenz, Silvia M Bacot, D. Lowy, 2003, Clinical immunology.

Evaluation of methods for transient transfection of a murine macrophage cell line, RAW 264.7.

M. Frazier-Jessen, R. Nordan, C. Thompson, 1999, BioTechniques.

Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions

D. Lowy, J. Schiller, P. Day, 2017, Molecular therapy. Methods & clinical development.

Human papillomavirus capsids preferentially bind and infect tumor cells

D. Lowy, J. Schiller, Rhonda C. Kines, 2016, International journal of cancer.

Human alpha-defensins block papillomavirus infection.

D. Lowy, J. Lubkowski, J. Schiller, 2006, Proceedings of the National Academy of Sciences of the United States of America.

A Human Papillomavirus (HPV) In Vitro Neutralization Assay That Recapitulates the In Vitro Process of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies

D. Lowy, J. Schiller, P. Day, 2012, Clinical and Vaccine Immunology.

Mouse model of cervicovaginal papillomavirus infection.

P. Day, C. Thompson, N. Çuburu, 2015, Methods in molecular biology.